mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.05 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.06 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.07 |